DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Study to evaluate the efficacy of DSM265 as a causal prophylactic in a standardized and
validated Human Challenge model using direct venous inoculation of aseptic, purified,
cryopreserved, vialed Plasmodium falciparum sporozoites.
Phase:
Phase 1
Details
Lead Sponsor:
Medicines for Malaria Venture
Collaborator:
Institute of Tropical Medicine, University of Tuebingen
Treatments:
Atovaquone Atovaquone, proguanil drug combination Proguanil